Return-Path: <admin@aspireindia.co.in>
Delivered-To: govancoz+spam@zacp120.webway.host
Received: from zacp120.webway.host
	by zacp120.webway.host with LMTP
	id CLVnNRZC02jGoSQA8rC0kQ
	(envelope-from <admin@aspireindia.co.in>)
	for <govancoz+spam@zacp120.webway.host>; Wed, 24 Sep 2025 02:57:58 +0200
Return-path: <admin@aspireindia.co.in>
Envelope-to: recep@govan.co.za
Delivery-date: Wed, 24 Sep 2025 02:57:58 +0200
Received: from vps.aviwebhosting.com ([103.154.184.57]:34232)
	by zacp120.webway.host with esmtps  (TLS1.3) tls TLS_AES_256_GCM_SHA384
	(Exim 4.98.2)
	(envelope-from <admin@aspireindia.co.in>)
	id 1v1DpU-0000000A3bO-0faI
	for recep@govan.co.za;
	Wed, 24 Sep 2025 02:57:58 +0200
Received: from ws-dip-gc02.diplomat.com.mt (c155-179.i01-7.onvol.net [212.56.155.179])
	by vps.aviwebhosting.com (Postfix) with ESMTPA id F097284BBDD;
	Mon, 22 Sep 2025 11:00:41 +0530 (IST)
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/simple; d=aspireindia.co.in;
	s=default; t=1758519053;
	bh=3jOSNYYfJptjszgTsTF/D4uPmh4HaZQaTR6vaYTYT/o=;
	h=Subject:To:From:Date:Reply-To;
	b=FFFzP3wvejeHETttCshzF/N6x5ox1qXfc1jDcCPEdkkH9FvG7upZtgjas5CmH9lC1
	 xgTzrIATQbK5lt6Lyfa8UQny2QqbnhMJ6dHsTp+MZ+TlsHMPgaJNMltJXEfLDrw+oU
	 MIXQiBD6mm9YEzQlhSxNrIXtOXDDebC5CyWRxfnM=
Content-Type: multipart/alternative; boundary="===============1176083027=="
MIME-Version: 1.0
To: Recipients <admin@aspireindia.co.in>
From: "Dr. Shingo Iwamoto" <admin@aspireindia.co.in>
Date: Mon, 22 Sep 2025 07:30:17 +0200
Reply-To: drshingoiwamotopharm1@gmail.com
X-Spam-Status: Yes, score=9.3
X-Spam-Score: 93
X-Spam-Bar: +++++++++
X-Spam-Report: =?ISO-8859-1?Q?Spam_detection_software=2C_running_on_the_system_=22zacp120=2Ewebway?= =?ISO-8859-1?Q?=2Ehost=22=2C=0A_has_identified_this_incoming_email_a?= =?ISO-8859-1?Q?s_possible_spam=2E__The_original=0A_message_has_been_?= =?ISO-8859-1?Q?attached_to_this_so_you_can_view_it_or_label=0A_simil?= =?ISO-8859-1?Q?ar_future_email=2E__If_you_have_any_questions=2C_see=0A_?= =?ISO-8859-1?Q?root=5C=40localhost_for_details=2E=0A_Content_preview?= =?ISO-8859-1?Q?=3A__Dear_Esteemed_Professional=2C_I_hope_this_messag?= =?ISO-8859-1?Q?e_finds_you=0A___well=2E_Nichi-Iko_Pharmaceutical_Co=2E=2C?= =?ISO-8859-1?Q?_Ltd=2E=2C_a_leading_pharmaceutical_manufacturer=0A__?= =?ISO-8859-1?Q?__based_in_Japan=2C_is_currently_seeking_a_qualified_?= =?ISO-8859-1?Q?individual_to_=5B=2E=2E=2E=5D_=0A_Content_analysis_de?= =?ISO-8859-1?Q?tails=3A___=289=2E3_points=2C_5=2E0_required=29=0A__p?= =?ISO-8859-1?Q?ts_rule_name______________description=0A_----_-------?= =?ISO-8859-1?Q?---------------_-------------------------------------?= =?ISO-8859-1?Q?-------------=0A__0=2E0_RCVD=5FIN=5FVALIDITY=5FRPBL=5FB?= =?ISO-8859-1?Q?LOCKED_RBL=3A_ADMINISTRATOR_NOTICE=3A_The_query_to=0A_?= =?ISO-8859-1?Q?_____________________________Validity_was_blocked=2E_?= =?ISO-8859-1?Q?_See=0A_____________________________https=3A//knowled?= =?ISO-8859-1?Q?ge=2Evalidity=2Ecom/hc/en-us/articles/20961730681243=0A_?= =?ISO-8859-1?Q?_____________________________for_more_information=2E=0A?= =?ISO-8859-1?Q?____________________________=5B103=2E154=2E184=2E57_l?= =?ISO-8859-1?Q?isted_in_bl=2Escore=2Esenderscore=2Ecom=5D=0A__0=2E0_?= =?ISO-8859-1?Q?URIBL=5FBLOCKED__________ADMINISTRATOR_NOTICE=3A_The_?= =?ISO-8859-1?Q?query_to_URIBL_was_blocked=2E=0A_____________________?= =?ISO-8859-1?Q?________See=0A_____________________________http=3A//w?= =?ISO-8859-1?Q?iki=2Eapache=2Eorg/spamassassin/DnsBlocklists#dnsbl-b?= =?ISO-8859-1?Q?lock=0A______________________________for_more_informa?= =?ISO-8859-1?Q?tion=2E=0A_____________________________=5BURI=3A_aspi?= =?ISO-8859-1?Q?reindia=2Eco=2Ein=5D=0A__4=2E5_URIBL=5FDBL=5FSPAM____?= =?ISO-8859-1?Q?_____Contains_a_spam_URL_listed_in_the_Spamhaus_DBL=0A_?= =?ISO-8859-1?Q?____________________________blocklist=0A_____________?= =?ISO-8859-1?Q?________________=5BURI=3A_aspireindia=2Eco=2Ein=5D=0A?= =?ISO-8859-1?Q?_-0=2E0_SPF=5FPASS_______________SPF=3A_sender_matche?= =?ISO-8859-1?Q?s_SPF_record=0A_-0=2E1_DKIM=5FVALID_____________Messa?= =?ISO-8859-1?Q?ge_has_at_least_one_valid_DKIM_or_DK_signature=0A_-0=2E1?= =?ISO-8859-1?Q?_DKIM=5FVALID=5FAU__________Message_has_a_valid_DKIM_?= =?ISO-8859-1?Q?or_DK_signature_from_author's=0A_____________________?= =?ISO-8859-1?Q?________domain=0A_-0=2E1_DKIM=5FVALID=5FEF__________M?= =?ISO-8859-1?Q?essage_has_a_valid_DKIM_or_DK_signature_from=0A______?= =?ISO-8859-1?Q?_______________________envelope-from_domain=0A__0=2E1?= =?ISO-8859-1?Q?_DKIM=5FSIGNED____________Message_has_a_DKIM_or_DK_si?= =?ISO-8859-1?Q?gnature=2C_not_necessarily_valid=0A__0=2E2_FREEMAIL=5FR?= =?ISO-8859-1?Q?EPLYTO=5FEND=5FDIGIT_Reply-To_freemail_username_ends_?= =?ISO-8859-1?Q?in_digit=0A_____________________________=5Bdrshingoiw?= =?ISO-8859-1?Q?amotopharm1=28at=29gmail=2Ecom=5D=0A__0=2E0_RCVD=5FIN?= =?ISO-8859-1?Q?=5FVALIDITY=5FSAFE=5FBLOCKED_RBL=3A_ADMINISTRATOR_NOT?= =?ISO-8859-1?Q?ICE=3A_The_query_to=0A______________________________V?= =?ISO-8859-1?Q?alidity_was_blocked=2E__See=0A_______________________?= =?ISO-8859-1?Q?______https=3A//knowledge=2Evalidity=2Ecom/hc/en-us/a?= =?ISO-8859-1?Q?rticles/20961730681243=0A____________________________?= =?ISO-8859-1?Q?__for_more_information=2E=0A_________________________?= =?ISO-8859-1?Q?____=5B103=2E154=2E184=2E57_listed_in_sa-accredit=2Eh?= =?ISO-8859-1?Q?abeas=2Ecom=5D=0A__0=2E0_RCVD=5FIN=5FVALIDITY=5FCERTI?= =?ISO-8859-1?Q?FIED=5FBLOCKED_RBL=3A_ADMINISTRATOR_NOTICE=3A_The=0A_?= =?ISO-8859-1?Q?____________________________query_to_Validity_was_blo?= =?ISO-8859-1?Q?cked=2E__See=0A_____________________________https=3A/?= =?ISO-8859-1?Q?/knowledge=2Evalidity=2Ecom/hc/en-us/articles/2096173?= =?ISO-8859-1?Q?0681243=0A______________________________for_more_info?= =?ISO-8859-1?Q?rmation=2E=0A_________________________=5B103=2E154=2E1?= =?ISO-8859-1?Q?84=2E57_listed_in_sa-trusted=2Ebondedsender=2Eorg=5D=0A?= =?ISO-8859-1?Q?__0=2E0_HTML=5FMESSAGE___________BODY=3A_HTML_include?= =?ISO-8859-1?Q?d_in_message=0A__3=2E0_KAM=5FSA=5FZA=5FABUSE________2?= =?ISO-8859-1?Q?TLD_Providers_prevalent_in_spam_abuse=0A__1=2E8_FREEM?= =?ISO-8859-1?Q?AIL=5FFORGED=5FREPLYTO_Freemail_in_Reply-To=2C_but_no?= =?ISO-8859-1?Q?t_From?=
X-Spam-Flag: YES
Subject:  ***SPAM***  Proposal for Strategic Business Collaboration.

You will not see this in a MIME-aware mail reader.
--===============1176083027==
Content-Type: text/plain; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body

Dear Esteemed Professional,
 I hope this message finds you well.
 Nichi-Iko Pharmaceutical Co., Ltd., a leading pharmaceutical manufacturer =
based in Japan, is currently seeking a qualified individual to serve as our=
 official representative in South Africa. This role involves managing miner=
al procurement and overseeing the establishment of our annex office in Sout=
h Africa under a five-year contractual agreement.
 This is a strategic opportunity to represent a respected global brand and =
play a key role in expanding our international presence. We are offering a =
competitive compensation package along with decision-making autonomy.
 If you are interested in learning more, kindly respond to this message for=
 further details.
 Warm regards,
Dr. Shingo Iwamoto
President & CEO
Nichi-Iko Pharmaceutical Co., Ltd.
5-4 Nihonbashi-Honcho 1-chome, Chuo-ku, Tokyo, Japan

--===============1176083027==
Content-Type: text/html; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body

<HTML><head><meta http-equiv=3D"Content-Type" content=3D"text/html; charset=
=3Diso-8859-1"/></head><BODY><P>Dear Esteemed Professional,</P>
<P>I hope this message finds you well.</P>
<P>Nichi-Iko Pharmaceutical Co., Ltd., a leading pharmaceutical manufacture=
r based in Japan, is currently seeking a qualified individual to serve as o=
ur official representative in South Africa. This role involves managing min=
eral procurement and overseeing the establishment of our annex office in So=
uth Africa under a five-year contractual agreement.</P>
<P>This is a strategic opportunity to represent a respected global brand an=
d play a key role in expanding our international presence. We are offering =
a competitive compensation package along with decision-making autonomy.</P>
<P>If you are interested in learning more, kindly respond to this message f=
or further details.</P>
<P>Warm regards,<BR>Dr. Shingo Iwamoto<BR>President &amp; CEO<BR>Nichi-Iko =
Pharmaceutical Co., Ltd.<BR>5-4 Nihonbashi-Honcho 1-chome, Chuo-ku, Tokyo, =
Japan</P></BODY></HTML>
--===============1176083027==--